Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma (Q74455614)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115346%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115346%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

Akhouri A Sinha

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115346%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Barry J Quast

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115346%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Michael J Wilson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115346%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Eduardo T Fernandes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115346%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Pratap K Reddy

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115346%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Stephen L Ewing

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115346%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Donald F Gleason

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115346%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 June 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115346%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115346%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115346%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115346%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

3141-3149

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115346%20AND%20SRC:MED&resulttype=core&format=json

Histologic grading of prostate cancer: a perspective

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10604

Natural history of progression after PSA elevation following radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10604

Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10604

Prostate cancer mortality in patients surviving more than 10 years after diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10604

Biological determinants of cancer progression in men with prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10604

Ability to predict biochemical progression using Gleason score and a computer-generated quantitative nuclear grade derived from cancer cell nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10604

An enhanced prognostic system for clinically localized carcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10604

Future prospects in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10604

Immunohistochemical localization of cathepsin B in neoplastic human prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10604

Plasma membrane association of cathepsin B in human prostate cancer: biochemical and immunogold electron microscopic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10604

Cathepsin B and its endogenous inhibitors: the role in tumor malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10604

Immunocytochemical and immunoelectron microscopic demonstration of cathepsin B in human malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10604

Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10604

Molecular regulation, membrane association and secretion of tumor cathepsin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10604

Emerging roles for cysteine proteases in human biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10604

Tumor cell membrane cathepsin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10604

Ratio of cathepsin B to stefin A identifies heterogeneity within Gleason histologic scores for human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10604

Delineation of prognostic biomarkers in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10604

The value of serum prostate specific antigen determinations before and after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10604

A guide to the interpretation of serum prostate specific antigen levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10604

The Relationship of Prostate Specific Antigen Levels and Residual Tumor Volume in Stage a Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10604

Extraction and analysis of diagnostically useful proteins from formalin-fixed, paraffin-embedded tissue sections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10604

Localization of cathepsin B in normal and hyperplastic human prostate by immunoperoxidase and protein A-gold techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10604

A critical analysis of tumor morphology and hormone treatments in the untreated and estrogen-treated responsive and refractory human prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10604

An analysis of watchful waiting for clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10604

Results of conservative management of clinically localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10604

Long-term Survival Among Men With Conservatively Treated Localized Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10604

Cathepsin B expression in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10604

inferred from DOI database lookup

7 January 2021

based on heuristic

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10604

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCR.10604

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12115346%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference